NCT01437072View on ClinicalTrials.gov

Changing Diabetes® World Tour

CompletedOBSERVATIONAL
Enrollment

8,304

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
OTHER

No treatment given

The screening test includes a combination of a risk assessment questionnaire and biochemical tests.

Trial Locations (3)

3542

Novo Nordisk Investigational Site, Riyadh

2780-730

Novo Nordisk Investigational Site, Paço de Arcos

Unknown

Novo Nordisk Investigational Site, Dubai

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01437072 - Changing Diabetes® World Tour | Biotech Hunter | Biotech Hunter